Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral DNA polymerases are essential enzymes encoded by DNA viruses, responsible for the replication of viral genomes. They catalyze the synthesis of new DNA strands using deoxyribonucleotides as substrates and a pre-existing viral or host DNA strand as a template. These enzymes are central to viral genome replication and transcription, often functioning as multifunctional proteins due to the limited coding capacity of viral genomes. Viral DNA polymerase is an attractive antiviral drug target because it is highly conserved within virus families but sufficiently different from host cell enzymes to allow selective inhibition. Resistance can arise via mutations in key residues affecting substrate/inhibitor recognition. Ongoing research focuses on developing broad-spectrum inhibitors targeting conserved active site features across diverse viruses.
Inhibition of viral DNA polymerase activity, leading to termination of chain elongation or allosteric blockade of enzyme function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral DNA Polymerase (None).